A. Rachel Leheny - 07 Nov 2023 Form 4 Insider Report for CalciMedica, Inc. (CALC)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: By John Dunn, Attorney-in-Fact
Issuer symbol: CALC
Transactions as of: 07 Nov 2023
Net transactions value: +$6,680
Form type: 4
Filing time: 08 Nov 2023, 20:42:38 UTC
Previous filing: 07 Nov 2023
Next filing: 25 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CALC	Common Stock	Purchase	$6,680	+2,000	+12%	$3.34	18,840	07 Nov 2023	Direct	F1
holding	CALC	Common Stock						1,000	07 Nov 2023	By Spouse
holding	CALC	Common Stock						356,989	07 Nov 2023	By Valence Investments SPV IV, LLC	F2
holding	CALC	Common Stock						66,228	07 Nov 2023	By Valence Investments SPV V, LLC	F2
holding	CALC	Common Stock						316,109	07 Nov 2023	By Valence Investments SPV VI, LLC	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The weighted average purchase price for the transaction reported was $3.34, and the range of prices were between $3.30 and $3.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F2	The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC ("Valence IV"), Valence Investments SPV V, LLC ("Valence V") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the "Valence Securities"). The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein.

Content

The weighted average purchase price for the transaction reported was $3.34, and the range of prices were between $3.30 and $3.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.

The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC ("Valence IV"), Valence Investments SPV V, LLC ("Valence V") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the "Valence Securities"). The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein.